New search Show text from Guidelines
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSL01 ANTINEOPLASTIC AGENTS
L01E PROTEIN KINASE INHIBITORS
L01EA BCR-ABL tyrosine kinase inhibitors
L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
L01EC B-Raf serine-threonine kinase (BRAF) inhibitors
L01ED Anaplastic lymphoma kinase (ALK) inhibitors
L01EE Mitogen-activated protein kinase (MEK) inhibitors
L01EF Cyclin-dependent kinase (CDK) inhibitors
L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
L01EJ Janus-associated kinase (JAK) inhibitors
L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
L01EL Bruton's tyrosine kinase (BTK) inhibitors
L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors
L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
L01EX Other protein kinase inhibitors
Last updated: 2024-01-26